Drew Hope joined Autolus in March 2018 as Director of Quality Operations. Autolus is a CAR T-cell company based in London with a portfolio of products in clinical development. Drew is a member of the Scientific Advisory Board of the Advanced-Therapy Manufacturing Community (amc) and former deputy chairman of the Manufacturing Advisory Committee of the BioIndustry Association. Before joining Autolus, Drew was the Head of Advanced Therapy Quality in Guy’s and St Thomas’ NHS Foundation Trust, working on a variety of cell and gene therapy products. Drew studied neurodegenerative diseases using cell modelling during his PhD at University College London and Post Doc at the Mayo Clinic, Jacksonville, and worked as a Regulation Manager in the Human Tissue Authority.